Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Naltrexone hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Naltrexone hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Naltrexone hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Product containing morphine sulfate and naltrexone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 20mg + naltrexone hydrochloride 800microgram m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 30mg + naltrexone hydrochloride 1.2mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 60mg + naltrexone hydrochloride 2.4mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 50mg + naltrexone hydrochloride 2mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 100mg + naltrexone hydrochloride 4mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Naltrexone hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |
Naltrexone hydrochloride 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |
Naltrexone hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |
Naltrexone hydrochloride 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |
Naltrexone hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |
Naltrexone hydrochloride 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |
Morphine sulfate 30mg + naltrexone hydrochloride 1.2mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 100mg + naltrexone hydrochloride 4mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 60mg + naltrexone hydrochloride 2.4mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 50mg + naltrexone hydrochloride 2mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Morphine sulfate 20mg + naltrexone hydrochloride 800microgram prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naltrexone hydrochloride |
Inferred relationship |
Some |
|
Naltrexone hydrochloride 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |
Naltrexone hydrochloride 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |
Naltrexone hydrochloride 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Naltrexone hydrochloride |
Inferred relationship |
Some |
1 |